Questions across 2 calls

Sanjay Kumar

ithought PMS

Anthem Biosciences Limited

Anthem Biosciences Limited CC-Nov25.pdf · 2025-11-10

Thanks for the opportunity. First set of questions on peptides. I think we have 10 peptide programs. Am I right? If you can give the breakup of these programs, how many are for GLP - 1s or both generic and others in the pipeline or other therapies, like say peptide drug conjugates, if you can give a sense of your peptide programs?

Got it. These generic GLP 1s, have we done the process validation for semaglutide? Have we, are we going to file DMF for semaglutide? What is our strategy? Do we have any signed deals for generic sema?

Multi Commodity Exchange of India Limited

Multi Commodity Exchange of India Limited CC-Dec23.pdf · 2024-02-12

Hi sir, thanks for the opportunity. Every quarter, there are questions on the breakup of transaction income and other operating income. It would be great if you could include these data points in the presentation. First question on coal exchange. Apparently, IEX has submitted a presentation to the Ministry and that the media articles saying that we set up in 1 year. Any comments on this? And where are we in this coal exchange thing?

So, we'll be competing with IEX for the spot or for both spot and futures?